Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-04

FDA Approved: TEMBEXA — Original Application (Emergent BioDefense Operations Lansing LLC)

View source ↗

Summary

FDA approved TEMBEXA (brincidofovir) under the original NDA (NDA214460) for the treatment of smallpox (Variola virus), developed by Emergent BioDefense Operatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TEMBEXA (BRINCIDOFOVIR)

Snippet

ORIG AP for TEMBEXA (BRINCIDOFOVIR)